OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 123 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $532,000 | -49.0% | 1,239,113 | -33.3% | 0.00% | -100.0% |
| Q1 2016 | $1,044,000 | -63.6% | 1,858,425 | +11.3% | 0.00% | -50.0% |
| Q4 2015 | $2,870,000 | -52.8% | 1,669,441 | -42.1% | 0.00% | -60.0% |
| Q3 2015 | $6,082,000 | -57.2% | 2,882,824 | +0.5% | 0.01% | -44.4% |
| Q2 2015 | $14,200,000 | -30.9% | 2,869,069 | +9.3% | 0.01% | -30.8% |
| Q1 2015 | $20,549,000 | +33.0% | 2,624,658 | +3.0% | 0.01% | +30.0% |
| Q4 2014 | $15,445,000 | +70.8% | 2,548,737 | +20.1% | 0.01% | +66.7% |
| Q3 2014 | $9,041,000 | -17.0% | 2,122,553 | +20.4% | 0.01% | -14.3% |
| Q2 2014 | $10,895,000 | -6.4% | 1,763,071 | -1.5% | 0.01% | -12.5% |
| Q1 2014 | $11,637,000 | -7.9% | 1,790,586 | -20.2% | 0.01% | -11.1% |
| Q4 2013 | $12,634,000 | -23.1% | 2,244,312 | -16.2% | 0.01% | -25.0% |
| Q3 2013 | $16,420,000 | – | 2,678,652 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 5,427,559 | $2,334,000 | 1.60% |
| Scale Management, LLC | 1,312,575 | $564,000 | 1.34% |
| Foresite Capital Management III, LLC | 2,542,575 | $1,093,000 | 0.75% |
| BVF INC/IL | 5,252,100 | $2,258,000 | 0.48% |
| TIVERTON ASSET MANAGEMENT LLC | 45,313 | $4,261,000 | 0.18% |
| Baupost Group | 22,268,399 | $9,575,000 | 0.13% |
| Rhenman & Partners Asset Management AB | 1,200,000 | $516,000 | 0.09% |
| NEA Management Company, LLC | 370,900 | $1,595,000 | 0.08% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $2,649,000 | 0.06% |
| Palo Alto Investors LP | 1,673,024 | $719,000 | 0.05% |